The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice
Open accessAbstract
B lymphocytes can both positively and negatively regulate cellular immune responses. Previous studies have demonstrated augmented T cell-mediated tumor immunity in genetically B cell-deficient mice, suggesting that therapeutic B cell depletion would enhance tumor immunity. To test this hypothesis and quantify B cell contributions to T cell-mediated anti-tumor immune responses, mature B cells were depleted from wild-type adult mice using CD20 mAb prior to syngeneic B16 melanoma tumor transfers. Remarkably, s.c. tumor volume and lung metastasis were increased 2-fold in B cell-depleted mice. Effector-memory and IFN-γ–or TNF-α–secreting CD4+ and CD8+ T cell induction was significantly impaired in B cell-depleted mice with tumors. Tumor Ag-specific CD8+ T cell proliferation was also impaired in tumor-bearing mice that lacked B cells. Thus, B cells were required for optimal T cell activation and cellular immunity in this in vivo nonlymphoid tumor model. Although B cells may not have direct effector roles in tumor immunity, impaired T cell activation, and enhanced tumor growth in the absence of B cells argue against previous proposals to augment tumor immunity through B cell depletion. Rather, targeting tumor Ags to B cells in addition to dendritic cells is likely to optimize tumor-directed vaccines and immunotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
T cell receptor antagonist peptides induce positive selection
Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., & Carbone, F. R. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 2,858
Barnden, M. J., Allison, J., Heath, W. R., & Carbone, F. R. (1998) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.1998.00709.x · Cited by 1,489
Selection of Successive Tumour Lines for Metastasis
FIDLER, I. J. (1973) · Nature New Biology · doi:10.1038/newbio242148a0 · Cited by 1,361
Yanaba, K., Bouaziz, J.-D., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.017 · Cited by 1,238
Self-citationOverwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M., & Tedder, T. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36030 · Cited by 913
Self-citationDe novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 715
Uchida, J., Hamaguchi, Y., Oliver, J. A., Ravetch, J. V., Poe, J. C., Haas, K. M., & Tedder, T. F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040119 · Cited by 642
Self-citationIntragenic tandem repeats generate functional variability
Verstrepen, K. J., Jansen, A., Lewitter, F., & Fink, G. R. (2005) · Nature Genetics · doi:10.1038/ng1618 · Cited by 616
DiLillo, D. J., Matsushita, T., & Tedder, T. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05137.x · Cited by 432
Self-citationRegulatory B cells as inhibitors of immune responses and inflammation
Bouaziz, J., Yanaba, K., & Tedder, T. F. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00661.x · Cited by 425
Self-citationB cells inhibit induction of T cell-dependent tumor immunity
Qin, Z., Richter, G., Schüler, T., Ibe, S., Cao, X., & Blankenstein, T. (1998) · Nature Medicine · doi:10.1038/nm0598-627 · Cited by 419
DiLillo, D. J., Hamaguchi, Y., Ueda, Y., Yang, K., Uchida, J., Haas, K. M., Kelsoe, G., & Tedder, T. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.361 · Cited by 385
Self-citationInhibitory Effects of B Cells on Antitumor Immunity
Inoue, S., Leitner, W. W., Golding, B., & Scott, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3766 · Cited by 337
B‐lymphocyte contributions to human autoimmune disease
Yanaba, K., Bouaziz, J., Matsushita, T., Magro, C. M., St.Clair, E. W., & Tedder, T. F. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00646.x · Cited by 326
Self-citationTherapeutic B cell depletion impairs adaptive and autoreactive CD4 + T cell activation in mice
Bouaziz, J.-D., Yanaba, K., Venturi, G. M., Wang, Y., Tisch, R. M., Poe, J. C., & Tedder, T. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709205105 · Cited by 314
Self-citationPrimary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells
Crawford, A., MacLeod, M., Schumacher, T., Corlett, L., & Gray, D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3498 · Cited by 313
B Lymphocytes Regulate Dendritic Cell (Dc) Function in Vivo
Moulin, V., Andris, F., Thielemans, K., Maliszewski, C., Urbain, J., & Moser, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.475 · Cited by 261
Linton, P.-J., Bautista, B., Biederman, E., Bradley, E. S., Harbertson, J., Kondrack, R. M., Padrick, R. C., & Bradley, L. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021290 · Cited by 242
Depletion of B Cells in Murine Lupus: Efficacy and Resistance
Ahuja, A., Shupe, J., Dunn, R., Kashgarian, M., Kehry, M. R., & Shlomchik, M. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3351 · Cited by 239
Shah, S., Divekar, A. A., Hilchey, S. P., Cho, H.-M., Newman, C. L., Shin, S.-U., Nechustan, H., Challita-Eid, P. M., Segal, B. M., Yi, K. H., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21177 · Cited by 227
Xiu, Y., Wong, C. P., Bouaziz, J.-D., Hamaguchi, Y., Wang, Y., Pop, S. M., Tisch, R. M., & Tedder, T. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2863 · Cited by 225
Self-citationA Critical Role for B Cells in the Development of Memory CD4 Cells
Linton, P.-J., Harbertson, J., & Bradley, L. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5558 · Cited by 219
Hasegawa, M., Hamaguchi, Y., Yanaba, K., Bouaziz, J.-D., Uchida, J., Fujimoto, M., Matsushita, T., Matsushita, Y., Horikawa, M., Komura, K., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060205 · Cited by 215
Self-citationHamaguchi, Y., Uchida, J., Cain, D. W., Venturi, G. M., Poe, J. C., Haas, K. M., & Tedder, T. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4389 · Cited by 212
Self-citationRivera, A., Chen, C.-C., Ron, N., Dougherty, J. P., & Ron, Y. (2001) · International Immunology · doi:10.1093/intimm/13.12.1583 · Cited by 204
Ehst, B. D., Ingulli, E., & Jenkins, M. K. (2003) · American Journal of Transplantation · doi:10.1046/j.1600-6135.2003.00246.x · Cited by 195
Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.
Seliger, B., Wollscheid, U., Momburg, F., Blankenstein, T. J. F., & Huber, C. (2001) · PubMed · Cited by 195
Homann, D., Tishon, A., Berger, D. P., Weigle, W. O., von Herrath, M. G., & Oldstone, M. B. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9208-9216.1998 · Cited by 158
CD8 T cell memory in B cell-deficient mice.
Asano, M. S., & Ahmed, R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2165 · Cited by 158
Yanaba, K., Hamaguchi, Y., Venturi, G. M., Steeber, D. A., Clair, E. W. S., & Tedder, T. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1369 · Cited by 147
Self-citationCoughlin, C. M., Vance, B. A., Grupp, S. A., & Vonderheide, R. H. (2003) · Blood · doi:10.1182/blood-2003-07-2379 · Cited by 140
Barberá‐Guillem, E., Nelson, M. B., Barr, B. L., Nyhus, J. K., May, K. F., Feng, L., & Sampsel, J. W. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/pl00006672 · Cited by 138
Steeber, D. A., Engel, P., Miller, A. S., Sheetz, M. P., & Tedder, T. F. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.952 · Cited by 134
Self-citationZhou, L., Smith, H. M., Waldschmidt, T. J., Schwarting, R., Daley, J. F., & Tedder, T. F. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3884-3894.1994 · Cited by 134
Self-citationVaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma
Neelapu, S. S., Kwak, L. W., Kobrin, C. B., Reynolds, C. W., Janik, J. E., Dunleavy, K. M., White, T., Harvey, L. K., Pennington, R., Stetler‐Stevenson, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1290 · Cited by 111
Nakamura, K., Yoshikawa, N., Yamaguchi, Y., Kagota, S., Shinozuka, K., & Kunitomo, M. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01454-0 · Cited by 98
The Role of B Cells for in Vivo T Cell Responses to a Friend Virus-Induced Leukemia
Schultz, K. R., Klarnet, J. P., Gieni, R. S., HayGlass, K. T., & Greenberg, P. D. (1990) · Science · doi:10.1126/science.2118273 · Cited by 97
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells
Stoitzner, P., Green, L. K., Jung, J. Y., Price, K. M., Atarea, H., Kivell, B. M., & Ronchese, F. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0487-4 · Cited by 96
Anti-Tumor Immunity in B Lymphocyte-Deprived Mice
Brodt, P., & Gordon, J. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.121.1.359 · Cited by 95
Tumours can act as adjuvants for humoral immunity
Brown, D. M., Fisher, T., Wei, C., Frelinger, J. G., & Lord, E. M. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01213.x · Cited by 92
Influence of Lymphocytes on the Presence and Organization of Dendritic Cell Subsets in the Spleen
Crowley, M. T., Reilly, C. R., & Lo, D. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4894 · Cited by 87
Hamel, K. M., Doodes, P. D., Cao, Y., Wang, Y., Martinson, J., Dunn, R., Kehry, M. R., Farkas, B., & Finnegan, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4994 · Cited by 85
Dobrzanski, M. J., Reome, J. B., & Dutton, R. W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.916 · Cited by 85
B Cell-Dependent TCR Diversification
Joao, C. M., Ogle, B. M., Gay-Rabinstein, C., Platt, J. L., & Cascalho, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4709 · Cited by 81
Enhanced Efficacy of Melanoma Vaccines in the Absence of B Lymphocytes
Perricone, M. A., Smith, K. A., Claussen, K. A., Plog, M. S., Hempel, D. M., Roberts, B., George, J. A. S., & Kaplan, J. M. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200407000-00003 · Cited by 81
Kim, S., Fridlender, Z. G., Dunn, R., Kehry, M. R., Kapoor, V., Blouin, A., Kaiser, L. R., & Albelda, S. Μ. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31816d1d6a · Cited by 75
DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy
Schultze, J. L., Grabbe, S., & von-Bergwelt-Baildon, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.016 · Cited by 75
Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor.
Brodt, P., & Gordon, J. (1978) · PubMed · Cited by 73
CD4+ AND B LYMPHOCYTES IN TRANSPLANTATION IMMUNITY
MOACH, P. A., Schreiber, H. W., & Rowley, D. A. (1993) · Transplantation · doi:10.1097/00007890-199306000-00027 · Cited by 68
Extralymphatic Tumors Prepare Draining Lymph Nodes to Invasion via a T-Cell Cross-Tolerance Process
Preynat‐Seauve, O., Contassot, E., Schuler, P., Piguet, V., French, L. E., & Huard, B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4494 · Cited by 45
Ritchie, D., Yang, J., Hermans, I. F., & Ronchese, F. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01517.x · Cited by 38
Immunological enhancement of primary tumor development and its prevention
Schreiber, H. W., Wu, T. H., Nachman, J. B., & Rowley, D. A. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0331 · Cited by 36
The role of the immune system in early epithelial carcinogenesis: B-ware the double-edged sword
Houghton, A. N., Uchi, H., & Wolchok, J. D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.026 · Cited by 30
Cited by
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Winer, D. A., Winer, S., Shen, L., Wadia, P. P., Yantha, J., Paltser, G., Tsui, H., Wu, P., Davidson, M. G., Alonso, M. N., et al. (2011) · Nature Medicine · doi:10.1038/nm.2353 · Cited by 1,050
Self-citationGermain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Ectopic lymphoid-like structures in infection, cancer and autoimmunity
Pitzalis, C., Jones, G. W., Bombardieri, M., & Jones, S. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3700 · Cited by 698
Fridman, W. H., Meylan, M., Petitprez, F., Sun, C.-M., Italiano, A., & Sautès-Fridman, C. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00619-z · Cited by 657
Metadata
- Authors
- DiLillo, D. J., Yanaba, K., & Tedder, T. F.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-01
- Volume
- 184
- Issue
- 7
- Pages
- 4006-4016
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1895813995
- Cited by
- 359
- References
- 54
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.